Concepedia

Joann Strnad

JS

Statistics

Publications

21

Citations

2.2K

H-Index

17

Active since

1988

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Eli Lilly (United States)

Cellular Research (United States)

Joann Strnad is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, life sciences, and signal transduction.

Publications per year

1988–2020

21

Publications

21

BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice

James R. Burke, Mark A. Pattoli, Kurt R. Gregor et al. · Journal of Biological Chemistry · 2003 · 547 citations · Full text

, , +13

Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165

Stephen T. Wrobleski, Ryan Moslin, Shuqun Lin et al. · Journal of Medicinal Chemistry · 2019 · 369 citations · Full text

, , +15

Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain

James R. Burke, Lihong Cheng, Kathleen M. Gillooly et al. · Science Translational Medicine · 2019 · 282 citations

, , +14

Identification and characterization of novel somatostatin antagonists.

R T Bass, Brian L. Buckwalter, Bhai Patel et al. · Molecular Pharmacology · 1996 · 147 citations · Full text

, , +17

A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma

Marina Li, Cindy Lin, Hui Deng et al. · Molecular Cancer Therapeutics · 2020 · 144 citations · Full text

, , +11

1–5 of 21